Search Our Website:
BIPC Logo

William Garvin, shareholder and co-chair of the firm's FDA section, was quoted in a Hunterbrook Media article entilted "FDA Heads to Court to Defend Unprecedented Decision Protecting Lung Drug Monopoly From Liquidia Competition."